One Pass Tirofiban In Management of Ischemic Stroke Thrombectomy In China

NCT04851457 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Stroke

Interventions

DRUG: Intravenous tirofiban combination therapy

Sponsor

Shanghai East Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]